Medication Adherence to Successful Tuberculosis Treatment Outcome among TB/HIV Patient at Prof. Dr. Sulianti Saroso Infectious Disease Hospital
Abstract
Tuberculosis/Human Immunodeficiency Virus (TB/HIV) co-infection has poorer treatment outcome compared to non-co-infected patients. To benefit from therapy and to avoid contracting treatment-resistant strains, the individuals must adherent to medications. There is limited information regarding successful TB treatment outcomes and their associated factors. Thus, the study was designed to identify medication adherence associated with treatment outcomes among TB/HIV Patients at Prof. Dr. Sulianti Saroso Infectious Disease Hospital. This research was an observational study with retrospective approach from January 2015 to December 2017 by taking data from medical records and TB-01 form of TB/HIV patients in the outpatient clinic of the disease which would be used as a sample. Regarding compliance in treatment with first visit for 2-4 months, an approach using secondary data which were TB-01 Form, as well as HIV Care and Antiretroviral Therapy summary forms was used. The statistical analysis used was the bivariate analysis with the chi-square test as the statistical test. A total of 114 patients were included in the study. The outcome of treatment success obtained from this study had a patient cure rate of 91.30%. There is a significant relationship between medication adherence to successful tuberculosis treatment outcome with p-value= 0.012; OR= 5.684. There is a meaningful relation between medication compliance with treatment outcome. It is when on medication adherence, the treatment results can be declared cured in accordance with predetermined criteria, while when not on medication adherence, the treatment results are not declared cured.
Keywords
Full Text:
PDFReferences
UNAIDS. Unaids report shows that 19 million of the 35 million people living with HIV today do not know that they have the virus | UNAIDS. Press Release. Geneva. 2014.
Wijayanti F; Tarmizi S; Tobing V; Nisa T; Akhtar M; Trihandini I; Djuwita R. From the Millennium Development Goals to Sustainable Development Goals.: The response to the HIV epidemic in Indonesia: challenges and opportunities. Journal of Virus Eradication. 2016;2:27–31.
Floyd K, Glaziou P, Houben RMGJ, Sumner T, White RG, Raviglione M. Global tuberculosis target and milestonbes set for 2016-2035: Definition and rationale. International Journal of Tuberculosis Lung Disease. 2018;227:723–30.
Kemenkes RI. Estimasi dan Proyekjsi HIV/AIDS di Indonesia Tahun 2015-2019. In: Direktorat Jenderal Pencegahan dan Pengendalian Penyakit. Jakarta; 2017. p. 1689–99.
Mitku AA, Dessie ZG, Muluneh EK, Workie DL. Prevalence and associated factors of TB/HIV co-infection among HIV Infected patients in Amhara region, Ethiopia. African Health Science. 2016;16:588.
World Health Organization. WHO treatment guidelines for drug-resistant tuberculosis : 2016 update. 2016
Elisabeth Sanchez-Padilla, Themba Dlamini, Alexandra Ascorra, Sabine Rüsch-Gerdes, Zerihun Demissie Tefera, Philippe Calain, Roberto de la Tour, Frauke Jochims ER, and Maryline Bonnet. High prevalence of multidrug-resistant tuberculosis, Swaziland, 2009-2010. Emerging Infectious Disease. 2012;18:29–27.
Kementrian Kesehatan Republik Indonesia. Program Pengendalian HIV AIDS dan PIMS di Fasilitas Kesehatan Tingkat Pertama: Petunjuk Teknis. Direktorat Jenderal Pencegah dan Pengendali Penyakit. 2016;
Williams BG, Gupta S, Wollmers M, Granich R. Progress and prospects for the control of HIV and tuberculosis in South Africa: a dynamical modelling study. Lancet Public Health. 2017;2:e223–30.
Hair JF, Black WC, Babin BJ, Anderson RE. Multivariate Data Analysis. Vectors. 2010.
Dahlan MS. Statistik Untuk Kedokteran Dan Kesehatan Deskriptif, Bivariat dan Multivariat. Dilengkapi Alikasi Menggunakan SPSS. 6th ed. Jatinagor: Alqaprint; 2014. Salemba Medika. 2014.
Nyoko YO, Putra IWGAE, Sawitri AAS. Hubungan Karakteristik Demografi, Klinis dan Faktor Risiko Terinfeksi HIV dengan Koinfeksi HIV/TB di Klinik Amertha Yayasan Kerti Praja Denpasar. Public Health and Preventive Medicine Archived Journal. 2014;2:95
Lusiana N, Karsana A, Noviyani R. Studi penggunaan obat anti tuberkulosis pada pasien TB-HIV/AIDS di RSUP Sanglah Denpasar tahun 2009. Fakultas MIPA Jurusan Farmasi Universitas Udayana Denpasar, Bali. Jurnal Manajemen Pelayanan Kesehatan. 2011;14(02):99-107
Wang H, Wolock TM, Carter A, Nguyen G, Kyu HH, Gakidou E, et al. Estimates of global, regional, and national incidence, prevalence, and mortality of HIV, 1980–2015: the Global Burden of Disease Study 2015. Lancet HIV. 2016;3:e361–87.
Wagner KD, Pollini RA, Patterson TL, Lozada R, Ojeda VD, Brouwer KC, et al. Cross-border drug injection relationships among injection drug users in Tijuana, Mexico. Drug Alcohol Dependence. 2011;113:236–41
Notoatmodjo S. Promosi Kesehatan dan Perilaku Kesehatan (edisi revisi 2012). Jakarta: rineka cipta. 2012.
Ernesha Webb Mazinyo, Lindsay Kim, Sikhethiwe Masuku,Joey L. Lancaster, Ronel Odendaal, Margot Uys, Laura Jean Podewils. Adherence to Concurrent Tuberculosis Treatment and Antiretroviral Treatment among Co-Infected Persons in South Africa, 2008–2010. PLoS One. 2016;11:1–13.
Kibret, Kelemu Tilahun AWY, Belaineh et al. Determinant Factors Associated with Occurrence of Tuberculosis among Adult People Living with HIV after Antiretroviral Treatment Initiation in Addis Ababa, Ethiopia: A Case Control Study. PLoS One. 2013;8:1–8.
Goodman Gilman A. Goodman & Gillman’s The Pharmacological Basis of Therapeutics. Mc Graw Hill Education. 2017.
Palomino J, Martin A. Drug Resistance Mechanisms in Mycobacterium tuberculosis. Antibiotics. 2014;3(3):317-40.
Anastasia S. Kolyva and Petros C. Karakousis. Old and New TB Drugs: Mechanisms of Action and Resistance, Understanding Tuberculosis - New Approaches to Fighting Against Drug Resistance, Pere-Joan Cardona, IntechOpen. 2015.
Albanna AS, Smith BM, Cowan D, Menzies D. Fixed-dose combination antituberculosis therapy: A systematic review and meta-analysis. European Respiratory Journal. 2013
Vermund SH, Yamamoto N. Co-infection with human immunodeficiency virus and tuberculosis in Asia. Tuberculosis. 2007;87:S18–25.
Chengchao Zhou, Jie Chu, Jinan Liu, Ruoyan Gai Tobe, Hong Gen, Xingzhou Wang, Wengui Zheng LX. Adherence to Tuberculosis Treatment among Migrant Pulmonary Tuberculosis Patients in Shandong, China: A Quantitative Survey Study. PLoS One. 2012;7:1–6.
Ifebunandu N, Ukwaja K OS. Treatment outcome of HIV-associated tuberculosis in a resource-poor setting. Tropical Doctor. 2012;42:74–6.
DOI: https://doi.org/10.15416/pcpr.v5i3.29166
Refbacks
- There are currently no refbacks.
